Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria
P Nordmann, L Poirel - Clinical Infectious Diseases, 2019 - academic.oup.com
Carbapenem resistance in gram-negative bacteria has caused a global epidemic that
continues to grow. Although carbapenemase-producing Enterobacteriaceae have received …
continues to grow. Although carbapenemase-producing Enterobacteriaceae have received …
Estimating the burden of antimicrobial resistance: a systematic literature review
Background Accurate estimates of the burden of antimicrobial resistance (AMR) are needed
to establish the magnitude of this global threat in terms of both health and cost, and to …
to establish the magnitude of this global threat in terms of both health and cost, and to …
Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance
A Amanati, S Sajedianfard, S Khajeh… - BMC infectious …, 2021 - Springer
Background This study aimed to investigate the epidemiology, microbiology, and risk factors
associated with mortality and multi-drug resistance bacterial bloodstream infections (BSIs) …
associated with mortality and multi-drug resistance bacterial bloodstream infections (BSIs) …
Bloodstream infections caused by Klebsiella pneumoniae in onco‐hematological patients: clinical impact of carbapenem resistance in a multicentre prospective …
EM Trecarichi, L Pagano, B Martino… - American journal of …, 2016 - Wiley Online Library
The aim of this study was to identify risk factors for mortality in patients suffering from
hematological malignancies (HMs) with bloodstream infections (BSIs) caused by Klebsiella …
hematological malignancies (HMs) with bloodstream infections (BSIs) caused by Klebsiella …
Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic …
SM Pouch, MJ Satlin - Virulence, 2017 - Taylor & Francis
Carbapenem-resistant Enterobacteriaceae (CRE) are a major global public health concern
and pose a serious threat to immunocompromised hosts, particularly patients with …
and pose a serious threat to immunocompromised hosts, particularly patients with …
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis
E Righi, AM Peri, PNA Harris, AM Wailan… - Journal of …, 2017 - academic.oup.com
Background: Carbapenem-resistant Gram-negative bacteria are recognized as a cause of
difficult-to-treat infections associated with high mortality. Objectives: To perform a systematic …
difficult-to-treat infections associated with high mortality. Objectives: To perform a systematic …
Clinical and economic burden of carbapenem-resistant infection or colonization caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter …
X Zhen, C Stålsby Lundborg, X Sun, S Gu, H Dong - Antibiotics, 2020 - mdpi.com
Background: Carbapenem resistant Klebsiella pneumoniae (CRKP), Pseudomonas
aeruginosa (CRPA), and Acinetobacter baumannii (CRAB) pose significant threats to public …
aeruginosa (CRPA), and Acinetobacter baumannii (CRAB) pose significant threats to public …
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: analysis of …
P Tofas, A Skiada, M Angelopoulou, N Sipsas… - International journal of …, 2016 - Elsevier
Carbapenemase-producing Klebsiella pneumoniae (CP-Kp) are currently among the most
important nosocomial pathogens in many geographic regions. A retrospective study was …
important nosocomial pathogens in many geographic regions. A retrospective study was …
Infections due to carbapenem-resistant bacteria in patients with hematologic malignancies
R Lalaoui, E Javelle, S Bakour, C Ubeda… - Frontiers in …, 2020 - frontiersin.org
In developed countries, hematological malignancies (HM) account for 8 to 10% of cancers
diagnosed annually and one-third of patients with HM (HMP) are expected to die from their …
diagnosed annually and one-third of patients with HM (HMP) are expected to die from their …
Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer
A Stern, E Carrara, R Bitterman… - Cochrane Database …, 2019 - cochranelibrary.com
Background People with cancer with febrile neutropenia are at risk of severe infections and
mortality and are thus treated empirically with broad‐spectrum antibiotic therapy. However …
mortality and are thus treated empirically with broad‐spectrum antibiotic therapy. However …